Renal drug delivery with low-molecular-weight proteins: The effect of charge modifications on the body distribution of drug-lysozyme conjugates

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 6, Issue 1, 1999, Pages 1-8

  Kok, R N J ^a,b   Grijpstra, F ^a   Nederhoed, K H ^a   Moolenaar, F ^a   De Zeeuw, D ^a   Meijer, D K F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Utrecht Inst Drug Explor   (Netherlands)

Author keywords

Conjugates; Drug delivery; Lysozyme; Protein; Renal

Indexed keywords

AMINE; ISOTHIOCYANIC ACID; LYSOZYME;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MODIFICATION; COVALENT BOND; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG TARGETING; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT;

EID: 0033035543     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175499267093     Document Type: Article

References (39)

1. Bergmann, P., Kacenelenbogen, R., and Vizaet, A. 1984. Plasma clearance, tissue distribution, and catabolism of cationized albumins with increasing isoelectric points in the rat. Clin. Sci. 67:35-43.
2. Bernard, A., Amor, A. O., and Lauwerys, R. 1992. Charge-dependent renal uptake of beta2-microglobulin in conscious rats. Scand. J. Clin. Lab. Invest. 52:415-423.
3. Bianchi, C., Donadio, C., Tramonti, G., Auner, I., Lorusso, P., Deleide, G., Lunghi, F., Vannucci, C., Vitali, S., and Ricchiuti, V. 1990. High and preferential accumulation in the kidney of anionic and cationic small proteins. Contrib. Nephrol. 83:39-46.
4. Brinkley, M. 1992. A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. Bioconjug. Chem. 3:2-13.
5. Bruins, A. P., Covey, T. R., and Henion, J. D. 1987. Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometry. Anal Chem. 59:2642-2646.
6. Christensen, E. I., Nielsen, S., Moestrup, S. K., Borre, C., Maunsbach, A. B., de Heer, E., Ronco, P., Hammond, T. G., and Verroust, P. 1995. Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. Eur. J. Cell Biol. 66:349-364.
7. Christensen, E. I., Rennke, H. G., and Carone, F. A. 1983. Renal tubular uptake of protein: Effect of molecular charge. Am. J. Physiol. 244:F436-F441.
8. Cojocel, C., Franzen-Sieveking, M., and Baumann, K. 1984. Dependence of renal protein reabsorption on glomerular filtration rate and infusion time. Pflugers Arch. Eur. J. Physiol. 402:34-38.
9. Franssen, E. J. F., Moolenaar, F., De Zeeuw, D., and Meijer, D. K. F. 1992. Renal specific delivery of sulfamethoxazole in the rat by coupling to the low molecular weight protein lysozyme via an acid-sensitive linker. Int. J. Pharm. 80:R15-R19.
10. Franssen, E. J. F., Moolenaar, F., De Zeeuw, D., and Meijer, D. K. F. 1993. Low molecular weight proteins as carriers for renal drug targeting: Naproxen coupled to lysozyme via the spacer L-lactic acid. Pharm. Res. 10:963-969.
11. Franssen, E. J. F., Moolenaar, F., De Zeeuw, D., and Meijer, D. K. F. 1994. Drug targeting to the kidney with low-molecular-weight proteins. Adv. Drug Deliv. Rev. 14:67-88.
12. Franssen, E. J. F., Van Amsterdam, R. G. M., Visser, J., Moolenaar, E., De Zeeuw, D., and Meijer, D. K. F. 1991. Low molecular weight proteins as carriers for renal drug targeting: Naproxen-lysozyme. Pharm. Res. 8:1223-1230.
13. Furitsu, H., Ogawara, K., Fujita, T., Yamashita, F., Takakura, Y., Sezaki, H., and Hashida, M. 1997. Pharmacokinetic analysis of scavenger receptor-mediated uptake of anionized proteins in the isolated perfused rat liver. Int. J. Pharm. 151:15-26.
14. Haas, M., De Zeeuw, D., Van Zanten, A., and Meijer, D. K. F. 1993. Quantification of renal low-molecular-weights protein handling in the intact rat. Kidney Int. 43:949-954.
15. Haas, M., Kluppel, C. A., Wartna, E., Moolenaar, F., Meijer, D. K. F., De Jong, P. E., and De Zeeuw, D. 1997. Drug targeting to the kidney: Renal delivery and degradation of a naproxen-lysozyme conjugate in vivo. Kidney Int. 52:1693-1699.
16. Haas, M., Meijer, D. K. F., Moolenaar, F., De Jong, P. E., and De Zeeuw, D. 1996. Renal drug targeting: Optimalization of renal pharmacotherapeutics. In International Yearbook of Nephrology 1996, ed. V. E. Andreucci and L. G. Fine, 3-11. Oxford: Oxford University Press.
17. Haas, M., Moolenaar, F., Elsinga, A., Kluppel, C. A., Tiebosch, T., De Jong, P. E., Meijer, D. K. F., and De Zeeuw, D. 1998a. Drug targeting to the urinary bladder: An increased urinary excretion and reduced renal toxicity of doxorubicin in the rat. Unpublished results.
18. Haas, M., Moolenaar, F., Meijer, D. K. F., De Jong, P. E., and De Zeeuw, D. 1998b. Renal targeting of an NSAID: Effects on renal prostaglandins. Clin. Sci. 95:603-609.
19. Habeeb, A. F. S. A. 1966. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14:328-336.
20. Habeeb, A. F. S. A. 1967. Antigenicity of chemically modified bovine serum albumin. J. Immunol. 99:1264-1276.
21. Hoare, D. G., and Koshland, D. E. 1967. A method for the quantitative modification and estimation of carboxylic acid groups in proteins. J. Biol. Chem. 242:2447-2453.
22. Hunter, W. M., and Greenwood, F. C. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496.
23. Hysing, J., and Tolleshaug, H. 1986. Quantitative aspects of the uptake and degradation of lysozyme in the rat kidney in vivo. Biochim. Biophys. Acta 887:42-50.
24. Jobbágy, A., and Kiraly, K. 1966. Chemical characterization of fluorescein isothiocyanate-protein conjugates. Biochim. Biophys. Acta 124:166-175.
25. Kang, Y. S., and Pardridge, W. M. 1994. Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin. Pharm. Res. 11:1257-1264.
26. Kok, R. J., Grijpstra, F., Walthuis, R. B., Moolenaar, F., De Zeeuw, D., and Meijer, D. K. F. 1999. Specific delivery of captopril to the kidneys with the prodrug captoprillysozyme, JPET, accepted.
27. Kooistra, T., Duursma, A. M., Bouma, J. M. W., and Gruber, M. 1980. Effect of size and charge on endocytosis of lysozyme derivatives by sinusoidal rat liver cells in vivo. Biochim. Biophys. Acta 631:439-450.
28. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin Phenol reagent. J. Biol. Chem. 193:265-275.
29. Maack, T., Park, C. H., and Camargo, M. J. F. 1985. Renal filtration, transport, and metabolism of proteins. In The kidney, physiology and pathophysiology, ed. D. W. Seldin and G. Giebisch, 1773-1803. New York: Raven Press.
30. Moestrup, S. K., Cui, S., Vorum, H., Bregengard, C., Bjorn, S. E., Norris, K., Gliemann, J., and Christensen, E. I. 1995. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J. Clin. Invest. 96:1404-1413.
31. Nishida, K., Mihara, K., Takino, T., Nakane, S., Takakura, Y., Hashida, M., and Sezaki, H. 1991. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver. Pharm. Res. 8:437-444.
32. Purtell, J. N., Pesce, A. J., Clyne, D. H., Miller, W. C., and Pollak, V. E. 1979. Isoelectric point of albumin: Effect on renal handling of albumin. Kidney Int. 16:366-376.
33. Soyez, H., Schacht, E., and Vanderkerken, S. 1996. The crucial role of spacer groups in macromolecular prodrug design. Adv. Drug Deliv. Rev. 21:81-106.
34. Steffens, A. B. 1969. A method for frequent sampling of blood and continuous infusion of fluids without disturbing the animal. Physiol. Behav. 4:833-836.
35. Takakura, Y., Fujita, T., Furitsu, H., Nishikawa, M., Sezaki, H., and Hashida, M. 1994a. Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors. Int. J. Pharm. 105:19-29.
36. Takakura, Y., Mihara, K., and Hashida, M. 1994b. Control of the disposition profiles of proteins in the kidney via chemical modification. J. Contr. Rel. 28:111-119.
37. Van der Sluijs, P., Costing, R., Weitering, J. G., Hardonk, M. J., and Meijer, D. K. F. 1985. Biliary excretion of FITC metabolites after administration of FITC labeled asialo orosomucoid as a measure of lysosomal proteolysis. Biochem. Pharmacol. 34:1399-1405.
38. Van der Sluijs, P., Bootsma, H. P., Postema, B., Moolenaar, F., and Meijer, D. K. F. 1986. Drug targeting to the liver with lactosylated albumins. Does the glycoprotein target the drug, or is the drug targeting the glycoprotein? Hepatology 6:723-728.
39. Yamada, H., Imoto, T., Fujita, K., Okazaki, K., and Motomura, M. 1981. Selective modification of aspartic acid-101 in lysozyme by corbodiimide reaction. Biochemistry 20:4836-4842.